6533b7d8fe1ef96bd126ab9b
RESEARCH PRODUCT
Beals–Hecht syndrome and choroidal neovascularization
Ruth López-lizcanoManuel Díaz-llopisJ. Fernando ArevaloJ Luis MullorJosé M. MillánRoberto Gallego-pinazosubject
medicine.medical_specialtyVisual acuityAmsler gridgenetic structuresmedicine.diagnostic_testbusiness.industryeye diseasesOphthalmologyChoroidal neovascularizationOptical coherence tomographyOphthalmologyBeals-Hecht syndromeMedicineFluorescein angiogramMetamorphopsiasense organsRanibizumabmedicine.symptombusinessmedicine.drugdescription
PURPOSE To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. METHODS A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. RESULTS After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. CONCLUSIONS To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2010-07-01 | Clinical Ophthalmology |